Literature DB >> 630296

Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.

G Papaevangelou, G Frösner, J Economidou, S Parcha, A Roumeliotou.   

Abstract

Evidence of hepatitis B virus (HBV) and hepatitis A virus (HAV) infections was south in 148 multiply transfused patients with thalassaemia and in healthy controls (2040 for HBV and 217 for HAV). The prevalence of the HBV surface antigen or antibody to it was significantly higher in patients than in controls and increased with the number of blood transfusions. In contrast, the prevalence of antibody to HAV was significantly lower in patients than in controls and decreased with the number of blood transfusions. These results support the view that blood transfusion does not play any appreciable part in transmitting HAV. Indeed, regular blood transfusion, where donors almost all have HAV antibody, seems to give protection against infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630296      PMCID: PMC1603031          DOI: 10.1136/bmj.1.6114.689

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  The natural history of infectious hepatitis.

Authors:  S KRUGMAN; R WARD; J P GILES
Journal:  Am J Med       Date:  1962-05       Impact factor: 4.965

3.  Transfusion-associated hepatitis not due to viral hepatitis type A or B.

Authors:  S M Feinstone; A Z Kapikian; R H Purcell; H J Alter; P V Holland
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

4.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

5.  [Immunoelectrophoretic detection of the "hepatitis associated antigen" (Au-SH-antigen)].

Authors:  F Pesendorfer; O Krassnitzky; F Wewalka
Journal:  Klin Wochenschr       Date:  1970-01-01

6.  Viral hepatitis. Clinical and tissue culture studies.

Authors:  J D Boggs; J L Melnick; M E Conrad; B F Felsher
Journal:  JAMA       Date:  1970-11-09       Impact factor: 56.272

7.  Non-A, non-B post-transfusion hepatitis.

Authors:  J L Dienstag; H R Purcell; H J Alter; S M Feinstone; D C Wong; P V Holland
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

8.  Hepatitis-A-Antibody in commercial lots of immune serum globulin.

Authors:  G G Frŏsner; H Haas; G Hotz
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

9.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

10.  Seroepidemiological study of HBV infections in Athens, Greece.

Authors:  G Papaevangelou; A Kyriakidou; C Vissoulis; D Trichopoulos
Journal:  J Hyg (Lond)       Date:  1976-04
  10 in total
  9 in total

1.  Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia.

Authors:  Dimitrios Siagris; Alexandra Kouraklis-Symeonidis; Irini Konstantinidou; Myrto Christofidou; Ioannis Starakis; Alexandra Lekkou; Christos Papadimitriou; Alexandros Blikas; Nicholas Zoumbos; Chryssoula Labropoulou-Karatza
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

2.  Epidemiological characteristics of hepatitis B virus infection in Cyprus.

Authors:  G Papaevangelou; A Róumeliotou; M Chatziminas; M Kotsianopoulou; P Ioannou; E Trichopoulou; A Nestoridou
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

Review 3.  Epidemiology of hepatitis A and B.

Authors:  G J Papaevangelou
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

4.  Viral hepatitis A and B in hemodialysed patients.

Authors:  K Gmelin; B von Ehrlich; B Kommerell; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-04-01

5.  Hepatitis B virus infection in thalassaemia major treated in London and Athens.

Authors:  G Mieli-Vergani; D Vergani; Y White; A P Mowat; B Wonke; C J Kennedy; A Karameau; D Politis; M Laulicht; A V Hoffbrand
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

6.  Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia.

Authors:  Prakash J Vidja; J H Vachhani; S S Sheikh; P M Santwani
Journal:  Indian J Hematol Blood Transfus       Date:  2011-04-11       Impact factor: 0.900

7.  Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.

Authors:  G A Moroni; G Piacentini; S Terzoli; G Jean; G Masera
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

8.  Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients.

Authors:  P Dentico; R Buongiorno; A Volpe; A Zavoianni; D De Mattia; V Sabato
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

9.  Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.

Authors:  S De Virgiliis; G Fiorelli; S Fargion; G Cornacchia; G Sanna; P Cossu; V Murgia; A Cao
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.